Immunostaining of Cells Encapsulated in a 3D Hydrogel System
JoVE Encyclopedia of Experiments
Immunology
0 views • 3:39 min • July 8th, 2025
Take a multi-well plate containing mammalian cells encapsulated in a hydrogel system mimicking the natural extracellular matrix environment.
Remove the culture medium. Treat with a fixation buffer to crosslink the proteins, preserving cellular integrity.
Add a solution containing detergent to permeabilize the cellular membrane.
Introduce a blocking solution to prevent non-specific antibody binding in subsequent steps.
Add a primary antibody cocktail that enters cells and binds specifically to cytoplasmic intermediate filaments and the target transcription factor.
Remove the unbound antibodies. Introduce fluorescently labeled secondary antibodies and a nuclear stain to label the DNA fluorescently.
Remove the unbound molecules.
Mount the hydrogel culture onto a slide using a mounting medium.
Use a confocal microscope to observe the immunostained cells.
First, aspirate the medium from each well. Then, wash the wells with 1 milliliter of warm DPBS. After washing is completed, add 750 microliters of fixation solution to each well. Then, incubate the 24-well plate at 37 degrees Celsius for 30 minutes. After the incubation, aspirate the fixation solution from each of the wells, and discard the fixative in a hazardous waste container. Next, add 1 milliliter of DPBS to the sample and immediately discard the DPBS into a hazardous waste container.
Next, add 750 microliters of permeabilization solution to permeabilize the sample for one hour at room temperature on the rocker, at 15 revolutions per minute. After one hour, aspirate the permeabilization solution, and add 750 microliters of blocking solution to the sample. Leave the sample on the rocker at room temperature for three hours. Then, dilute the desired primary antibodies with the antibody dilution solution.
Next, add 500 microliters of the antibody solution to each sample. Incubate the samples overnight at 4 degrees Celsius. The following day, aspirate the primary antibody solution. Then, wash the samples with PBST for one hour thrice, at room temperature, at 15 revolutions per minute.
Next, dilute the appropriate secondary antibodies and 5 mg/ml of DAPI stock solution to achieve a final concentration of 2.5 micrograms per milliliter. Then, add 500 microliters of the solution to each sample. Next, use aluminum foil to cover the 24-well plate and incubate the plate at 4 degrees Celsius overnight.
The next day, aspirate the secondary antibody solution and wash the samples with PBST thrice, each for 30 minutes at room temperature on a rocker. Next, position a drop of hard set mounting medium on the surface of a glass slide and place the sample on the mounting medium. Finally, use nail polish to seal the samples to the glass cover slide to prevent contamination or sample movement.
Overview
This article describes a protocol for immunostaining mammalian cells encapsulated in a hydrogel system. The method preserves cellular integrity while allowing for the visualization of specific proteins using fluorescent antibodies.
Key Study Components
Area of Science
- Cell biology
- Immunohistochemistry
- Fluorescence microscopy
Background
- Immunostaining is a crucial technique for studying protein expression in cells.
- Hydrogel systems can mimic the extracellular matrix, providing a relevant environment for cell culture.
- Fluorescent labeling allows for the visualization of specific cellular components.
- Proper fixation and permeabilization are essential for successful antibody binding.
Purpose of Study
- To provide a detailed protocol for immunostaining cells in a hydrogel matrix.
- To demonstrate the effectiveness of fluorescent antibodies in visualizing target proteins.
- To ensure reproducibility and accuracy in cellular imaging techniques.
Methods Used
- Cell encapsulation in a hydrogel system.
- Fixation with a buffer to preserve cellular structure.
- Permeabilization of cell membranes for antibody access.
- Use of primary and secondary antibodies for specific protein labeling.
Main Results
- Successful immunostaining of cytoplasmic intermediate filaments and transcription factors.
- Visualization of labeled cells using confocal microscopy.
- Demonstration of the effectiveness of the hydrogel system in maintaining cell integrity.
- Clear imaging results indicating specific antibody binding.
Conclusions
- The protocol provides a reliable method for immunostaining cells in a hydrogel environment.
- Fluorescent labeling is effective for studying protein localization.
- This method can be applied to various studies in cell biology and tissue engineering.
Frequently Asked Questions
Executive Industry Relevance
Immunostaining of cells in 3D hydrogel systems enables physiologically relevant protein localization studies, supporting target validation in early discovery. This approach enhances predictive confidence by preserving native cellular architecture while permitting specific antigen detection. It informs go/no-go decisions by reducing mechanistic ambiguity in pathway analysis.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through specific protein detection in cytoplasmic intermediate filaments and transcription factors.
- Operational Value: Supports biological de-risking by confirming target engagement in a matrix-mimetic environment.
- Predictive Value: Facilitates portfolio triage via clear imaging of antibody-bound targets under confocal microscopy.
Screening & Assay Development
- Assay Readiness: Produces standardized, reproducible samples ready for downstream screening workflows.
- Quantitative Output: Generates fluorescent signals enabling measurable protein expression levels.
- Platform Reuse: Establishes a scalable immunostaining platform applicable across multiple cell types and targets.
Translational & Preclinical Research
- Translational Continuity: Maintains disease-relevant cellular context from discovery through preclinical validation.
- Risk-Adjusted Decisions: Supports advancement criteria via consistent, reproducible immunostaining readouts.
- Mechanistic De-risking: Clarifies pathway modulation effects through preserved 3D architecture and specific labeling.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from target validation to preclinical evaluation by providing reliable protein localization data.
- Discovery Biology: Supports hypothesis testing and pathway clarification via specific antigen binding in encapsulated cells.
- Screening: Delivers assay-ready, reproducible samples with quantitative fluorescence readouts for compound evaluation.
- Analytics: Enables comparative condition analysis through standardized confocal imaging and signal quantification.
- Translational Research: Connects to preclinical continuity by preserving extracellular matrix mimicry and cellular integrity.
- Enterprise Reuse: Functions as a reusable immunostaining capability across multiple projects and targets.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation, reduction of mechanistic ambiguity in protein localization.
- Operational Value: Standardization, reproducibility, and scalability of immunostaining workflows.
- Strategic Value: Improved go/no-go decisions, capital efficiency, and reduced late-stage biological risk.
- Portfolio Impact: Risk-adjusted prioritization and advancement decisions based on reliable imaging data.
Implementation Considerations
- Requires expertise in cell culture, hydrogel handling, and immunofluorescence techniques.
- Depends on access to confocal microscopy and fluorescent antibody reagents.
- Necessitates cross-team standardization of fixation, permeabilization, and blocking protocols.
- Involves adaptation considerations for different cell types and hydrogel formulations.
- Includes practical limitations such as antibody penetration depth in dense matrices and optimization of permeabilization times.
Biopharma FAQs
Hyaluronic-Acid Based Hydrogels for 3-Dimensional Culture of Patient-Derived Glioblastoma Cells
Related Videos
0 Views
Identifying Cell Surface Markers of Primary Neural Stem and Progenitor Cells by Metabolic Labeling of Sialoglycan
Related Videos
0 Views
Scalable Generation of Mature Cerebellar Organoids from Human Pluripotent Stem Cells and Characterization by Immunostaining
Related Videos
0 Views
Cellular Encapsulation in 3D Hydrogels for Tissue Engineering
Related Videos
0 Views
Tracking Hypoxic Signaling within Encapsulated Cell Aggregates
Related Videos
0 Views
FRET Imaging in Three-dimensional Hydrogels
Related Videos
0 Views
Light-mediated Formation and Patterning of Hydrogels for Cell Culture Applications
Related Videos
0 Views
Preparation of Chitosan-based Injectable Hydrogels and Its Application in 3D Cell Culture
Related Videos
0 Views
Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
Related Videos
0 Views
Production of Elastin-like Protein Hydrogels for Encapsulation and Immunostaining of Cells in 3D
Related Videos
0 Views
Last updated: 29 August 2026